Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The string “Liver function support” does not denote a single, specific molecular target (such as a receptor, enzyme, transporter, or gene). It is a broad clinical concept encompassing supportive strategies and devices intended to assist liver function, particularly in acute liver failure or acute-on-chronic liver failure. Examples include artificial extracorporeal liver support systems like the Molecular Adsorbents Recirculating System (MARS), which performs albumin dialysis to remove protein-bound toxins, and bioartificial liver systems that use living hepatocytes on biomaterial scaffolds to provide limited detoxification and synthetic activity. Because this term is not a discrete molecule or receptor, it should not be treated as a therapeutic “target” entity for drug–target mapping, and a more specific molecular target would be needed for structured curation.
Extracorporeal detoxification via albumin dialysis in artificial liver support systems such as Molecular Adsorbents Recirculating System (MARS). Toxin removal and metabolic support using bioartificial liver devices incorporating living hepatocytes and scaffolds to provide limited synthetic functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Liver function support.